Wednesday, August 27, 2014
Inquirer Daily News

FDA issues warning for weight-loss pill

The Food and Drug Administration issued a warning to consumers who use the weight loss supplement Slim-30 Herb after an agency lab analysis found it contained substances could endanger some patients with histories of heart disease, heart failure, arrhythmias, or stroke.

FDA issues warning for weight-loss pill

The Food and Drug Administration issued a warning to consumers who use the weight loss supplement Slim-30 Herb after an agency lab analysis found it contained substances could endanger some patients with histories of heart disease, heart failure, arrhythmias, or stroke.

Marketed as a natural supplement, the FDA lab analysis found the pills contained N-Desmythy sibutramine and traces of sibutramine, a medication sold as Meridia by the drug maker Abbott Laboratories. The drug is know to “substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke,” the FDA stated.

The agency said it has not received any reports of injuries associated with the Slim-30 Herb Supplement. Still, the FDA cautioned consumers to stop taking the supplement and return it for a full refund.

Click here to see the FDA alert on Slim-30 Herb Supplement.

To check out more Check Up items go to www.philly.com/checkup.

About this blog

Check Up covers major health events in our region and offers everything from personal health advice to an expert look at health reform. Read about some of our bloggers here.

For Inquirer.com. Portions of this blog may also be found in the Inquirer's Sunday Health Section

Michael R. Cohen, R.Ph. President, Institute for Safe Medication Practices
Daniel R. Hoffman, Ph.D. President, Pharmaceutical Business Research Associates
Latest Health Videos
Also on Philly.com:
Stay Connected